Doppler echocardiographic determinations, left ventricular (LV) fractional shortening (FS), cardiac output (CO), diastolic function parameter (E/A ratio) and carotid artery pulse wave velocity and stiffness were evaluated in 36 patients with essential hypertension before and after nisoldipine treatment. Blood pressure decreased significantly, and carotid artery width and fractional shortening increased significantly following nisoldipine administration (p<0.0001). Carotid artery pulse wave peak velocity did not change following the treatment period (p>0.05). In conclusion, short term nisoldipine administration improved blood pressure and LV systolic function, whereas LV diastolic function and carotid artery stiffness did not change. Nisoldipine did not alter serum biochemical parameters, including cholesterol, triglyceride, HDL-cholesterol, and LDL-cholesterol (p>0.05). Only one patient manifested symptoms of hypotension as an adverse effect of the drug. (Jpn Heart J 36: 629-637, 1995) ventricle (LV) and the blood vessel structure. The blood ejected by the left ventricle exerts a pressure leading to an eventual extension of the aorta and the arterial system. On the other hand, the properties of the vessels vary due to age,1,2) hypertension,3,4) atherosclerosis5,6) and total salt intake.7,8) Thus, performance of the LV affecting the amount of blood ejected to the periphery acts as the major dependent variable. Nevertheless, the structure of the arteries is also important. In both atherosclerosis and hypertension the non-invasive investigation of the carotid arteries is becoming increasingly popular, both in follow-up From the
HE blood pressure is established via the connection between the left ventricle (LV) and the blood vessel structure. The blood ejected by the left ventricle exerts a pressure leading to an eventual extension of the aorta and the arterial system. On the other hand, the properties of the vessels vary due to age,1,2) hypertension,3,4) atherosclerosis5,6) and total salt intake.7,8) Thus, performance of the LV affecting the amount of blood ejected to the periphery acts as the major dependent variable. Nevertheless, the structure of the arteries is also important. In both atherosclerosis and hypertension the non-invasive investigation of the carotid arteries is becoming increasingly popular, both in follow-up and the treatment of these entities.
Nisoldipine is a new calcium channel blocker of the dihydropyridine group.9) It resembles nifedipine in structure, although its pharmacological properties differ from those of nifedipine. Nisoldipine has minimal negative inotropic effects on cardiac muscle when compared to smooth muscle, at least 10 times less.10) The main objective of Nisoldipine therapy is to inhibit smooth muscle activity while maintaining the tonus within the coronary artery.10,11) In this investigation, we studied the effects of nisoldipine on carotid artery stiffness and LV function over the short term. ducer and Acuson 128 computed sonography. The bulb of the carotid artery as well as the extracranial tracing common carotid artery, internal and external carotid arteries were visualised when the patients were in the supine position with hyperextension of the neck (Figures 1 and 2 ). The common carotid artery, which is one centimeter proximal to the bulb, was visualized and M-mode echocardiography with simultaneous ECG was recorded. The carotid velocities were obtained from the common carotid arteries. The peak systolic carotid diameter was measured within the time interval of the peak flow velocity. An average 
MATERIALS AND METHODS

RESULTS
Treatment with nisoldipine led to a significant decrease in blood pressure (Table II) . Brachial systolic, diastolic and mean blood pressures were changed before and after treatment (p<0.0001). Heart rate was not changed. Carotid artery systolic and diastolic pressures were also altered after treatment (p<0.001). Left ventricular structure and functions are shown in Table III . While there was no significant change in LV end-diastolic diameter, end-systolic diameter was reduced significantly (p<0.04). However, reduction in systolic diameter resulted in changes of fractional shortening (p<0.04). LV mass decreased following treatment, but this was statistically insignificant. Posterior and interventricular septal wall thickness and cardiac output changes following treatment were insignificant. Diastolic filling parameters and systolic performance are presented in Tables I and III. Diastolic filling parameter   Table I .
Left Ventricular Diastolic Function Parameters before and after Treatment E-wave=peak early wave; A-wave=peak late wave. (E, A, E/A) changes were insignificant (p>0.05). Cardiac output was increased insignificantly because there was no significant difference in heart rate. Changes in serum lipid profile are shown in Table V . No significant changes were observed regarding cholesterol, HDL, LDL cholesterol and triglycerides. Nisoldipine did not alter renal function parameters (blood urea nitrogen, creatinine, uric acid). A significant reduction in systemic vascular resistance was observed (Table  III) . Changes in carotid artery stiffness and structure are shown in Table IV . A statistically significant increase was observed in carotid artery diastolic and systolic diameters while there was significantly decreased stiffness (Ep, p<0.001). Pulse wave velocity in the common carotid artery was not significantly altered.
DISCUSSION
Calcium channel blockers are currently used in atherosclerotic heart disease, left ventricular function disorders, hypertension and particularly in heart failure where diastolic functional impairment is the cause.17) Analysis of transmitral flow velocity has provided means of simple estimation and accurate noninvasive evaluation of diastolic filling, function.27) Doppler derived indexes of LV filling have been shown to correlate with radionuclide or cineangiographic measurements.28-30) The delay and reduction in LV early filling were noted in previous reports on diastolic dysfunction in hypertension.31) There are many factors that can influence LV early filling, including structural (hypertrophy) and dynamic (systolic performance, loading conditions, and heart rate) features, sympathetic drive, coronary blood flow, and myocardial perfusion.31) Recently there have been conflicting reports of the effects of calcium channel blockers on diastolic functions, suggesting improvement or no improvement in parameters. [18] [19] [20] Diastolic function parameters were not changed significantly during a 3 month nisoldipine trial. On the other hand, Nishimura et al20) testing verapamil over the short term, could not find any significant change in diastolic function of the left ventricle except an observed increase in the early rapid filling phase.
Using noninvasive techniques, the effects of nisoldipine on left ventricular function were investigated to a limited extent.9) Nisoldipine has been shown to normalize increased diastolic filling pressure and to improve ventricular relaxation. Diastolic parameters, especially isovolumic relaxation time, were found to decrease following the early stage of intravenous nisoldipine administration in patients with coronary artery disease.10) In our study, in patients with hypertension, no significant changes were observed in diastolic function parameters on Doppler echocardiography (initially E/A=0.98) after treatment with nisoldipine (E/A=0.96, p=0.791). Due to their major effect on vascular smooth muscle cells, dihydropyridines were employed in many hypertensives.9) Nisoldipine is reported to promote vascular compliance by reducing systemic vascular resistance via binding to dihydropyridine receptors in a time and voltage dependent fashion.9,11) Systemic vascular resistance was decreased in our patients. A previous study reported similar findings that vasodilation was more prominent.10) Particularly, nisoldipine reduces volume overload in hypertensives through vasodilation.9) The vasodilating action, then, is not a result of stimulation of vascular beta adrenoreceptors, but must be a result of direct action on vascular smooth muscle.10) Brachial and carotid artery blood pressures were decreased significantly after treatment (Table II) . This can be interpreted as being the result of afterload reduction associated with sympathetic counterregulation.10) Accordingly, we observed a marked reduction in systolic diameter whereas there was no significant change in diastolic diameter. This change led to an increase in fractional shortening and cardiac output (p=0.04 and p=0.203, respectively) and thereby an improvement in systolic function. Bopp et al observed an increase in systolic parameters over the short term.9) It is also reported that, as the compliance of the arteries increases using intravenous nisoldipine, the blood pressure is elevated.21,22) Therefore, measuring the arterial stiffness is important in identifying vascular wall overload noninvasively. This is done best using Doppler echocardiography.16) Kool et al have compared the diameter and the compliance of the carotid artery in otherwise healthy and smoking individuals.23) It was shown that there was a significant reduction in arterial compliance detected among hypertensive patients.24) In this study, although carotid artery diameter and stiffness were measured following nisoldipine administration, the difference was statistically insignificant. On the other hand no change in ventricular wall thickness and mass was observed (p>0.05). Previous studies reported that the reduction of left ventricular mass was due to lowering the concentration of intracellular calcium ions that is necessary for protein synthesis.11) It has been suggested by Devereux et al32) that the reduction of left ventricular hypertrophy with most antihypertensive therapy is caused by a reduction of peripheral vascular resistance and afterload to the left ventricle. In our study, reduction of left ventricular hypertrophy was not observed, possibly due to the short term of nisoldipine therapy. None of the patients complained of any adverse reactions, except for one patient who had severe hypotension during drug administration.
In conclusion, a new dihydropyridine analogue, nisoldipine, was found to be successful in reducing mean arterial blood pressure, improving cardiac systolic function, preserving diastolic function and decreasing peripheral arterial stiffness in patients with essential hypertension. No significant change in left ventricular mass was observed in short term usage of the drug.
